📰 Ming Wang News
Page 16 - Ming Wang News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Ming Wang. Real-time updates on events, politics, business and more.
October 14, 2022
/PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), a clinical stage biotech company focused on oncology, announced today that it has received clearance from...
September 28, 2022
Modern microscopic methods such as atomic force microscopy (AFM) have significantly increased our understanding of bitumen microstructure. This article will discuss this topic further, looking at applications and the industry’s future.
September 14, 2022
Seattle, Washington (PRWEB) September 14, 2022 -- The International Design Excellence Awards (IDEA)® 2022 Ceremony & Gala, held at Benaroya Hall in Seattle,
September 1, 2022
Handelsbanken Fonder AB cut its position in shares of Ambarella, Inc. (NASDAQ:AMBA – Get Rating) by 15.8% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 5,844 shares of the semiconductor company’s stock after selling 1,100 shares during the period. Handelsbanken Fonder […]
August 23, 2022
/PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research and clinical development in oncology, announced today...
August 2, 2022
/PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research and clinical development in oncology, announced today...
July 31, 2022
Capsized in the open ocean, Michael Beaudoin thought he would die alone – and almost did.
July 12, 2022
Cerity Partners LLC lessened its position in Ambarella, Inc. (NASDAQ:AMBA – Get Rating) by 56.6% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 4,809 shares of the semiconductor company’s stock after selling 6,278 shares during the quarter. Cerity Partners LLC’s holdings in Ambarella […]
July 8, 2022
Looking for a new doc? Weve got you covered.
June 30, 2022
/PRNewswire/ -- Phanes Therapeutics, Inc. (Phanes), an emerging leader in innovative discovery research and clinical development in oncology, announced today...